Quest Diagnostics (DGX) Tops Q4 EPS by 4c; offers guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $244.88 -0.64%
Revenue Growth %: +7.8%
Financial Fact:
Net revenues: 1.89B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +7.8%
Financial Fact:
Net revenues: 1.89B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $2.23, $0.04 better than the analyst estimate of $2.19. Revenue for the quarter came in at $2.62 billion versus the consensus estimate of $2.58 billion.
GUIDANCE:
Quest Diagnostics sees FY2025 EPS of $9.55-$9.80, versus the consensus of $9.72. Quest Diagnostics sees FY2025 revenue of $10.7-10.85 billion, versus the consensus of $10.671 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
- GameStop shares rise as CEO Cohen buys $26.4M in stock
- Iambic Therapeutics (IAM) files for proposed IPO
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
